M.P.Council of Science & Technology Invited Recruitment Application for RA & JRF

MP Council of Science & Technology, Bhopal invited application for “Research Associates (RA), and Junior Research Fellows (JRF)” .Rrecruitment of “Research Associates (RA) – Fellowship amount Rs. 30,000/- pm fixed and Junior Research Fellows (JRF) – Fellowship amount Rs. 20,000/- pm fixed” for its present and future projects. Candidates with following qualifications may apply in prescribed format given at portal “Job Opportunity@MPCOST” at Council’s website (www.mpcost.gov.in). … Continue reading M.P.Council of Science & Technology Invited Recruitment Application for RA & JRF

सीमैप के हर्बल कॉस्मेटिक्स का होगा मार्केट प्रोडक्शन

केंद्रीय औषधीय एवं सगंध पौधा संस्थान (सीमैप) द्वारा विकसित हर्बल कॉस्मेटिक उत्पादों के व्यावसायिक उत्पादन के लिए एक निजी कंपनी के साथ करार किया गया है। इस समझौते के तहत सीमैप द्वारा विकसित किए गए हर्बल उत्पादों- रिलैक्सोमैप, पेनज़ा, पेनछू, फ्लोमॉप और एक्ने प्रिवेंटिव फेसवॉश बनाने की तकनीक विकसित की गई है। औषधीय तथा सगंध पौधों के क्षेत्र में शोध एवं विकास के लिए कार्यरत … Continue reading सीमैप के हर्बल कॉस्मेटिक्स का होगा मार्केट प्रोडक्शन

CSIR-Summer Research Training Programme (CSIR-SRTP-2020)

Jorhat-based CSIR-NEIST got the mandate from DG, CSIR to organize and coordinate a country-wide CSIR-Summer Research Training Programme (CSIR-SRTP-2020). The North East Institute of Science and Technology (NEIST) is working towards ameliorating the stagnancy created in the academic scenario of the nation due to COVID-19 pandemic. online programme (CSIR-SRTP-2020) is going to be discharged through the faculties and mentors from 38 CSIR laboratories spread across the … Continue reading CSIR-Summer Research Training Programme (CSIR-SRTP-2020)

Umifenovir can be a safe, efficacious, affordable drug against COVID-19- CDRI, India

CSIR-Central Drug Research Institute(CDRI) Lucknow, has received permission for carrying out Phase III randomised, Double blind, Placebo controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir. The Phase III Clinical Trials will be carried out at King George’s Medical University (KGMU), Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) and ERA’s Lucknow Medical College & Hospital, Lucknow. Umifenovir is mainly used for … Continue reading Umifenovir can be a safe, efficacious, affordable drug against COVID-19- CDRI, India

Covifor is the first generic brand of Remdesivir

The approval of ‘COVIFOR’, the generic of Remdesivir by Drugs Controller General of India (DCGI), Hetero Healthcare Limited, a group company of Hetero is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which, will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra; while the other lot will be supplied to … Continue reading Covifor is the first generic brand of Remdesivir

DST India sets up joint science communication forum

Joint Science Communication Forum in a view to facilitate interaction, cooperation, and coordination amongst various public sector science communication institutions and agencies is initiated via The Department of Science & Technology (DST). The Forum brings together science communication efforts spread across various institutions and can help adoption of a common policy and best practices at a wider scale, ultimately aiming towards a national science communication framework. … Continue reading DST India sets up joint science communication forum

Indian Institute of Chemical Biology (IICB), has explored the neuro-invasive potential of SARSCoV-2

The team of researchers at CSIR-Indian Institute of Chemical Biology (IICB), Kolkata has explored the neuro-invasive potential of SARSCoV-2 and suggested that the virus may infect respiratory centre of the brain and attention should be focused on the respiratory centre of the central nervous system to search for mortality due to COVID 19. The paper published in ACS Chemical Neuroscience and supported by Science & … Continue reading Indian Institute of Chemical Biology (IICB), has explored the neuro-invasive potential of SARSCoV-2

Indian Govt invited application for NEWTON-BHABHA fund PhD Programme 2020-2021

The Newton Fund builds research and innovation partnerships with 17 active partner countries to support their economic development and social welfare, and to develop their research and innovation capacity for long-term sustainable growth. It has a total investment of £735 million from the United Kingdom (UK) Government until 2021, with matched resources from the partner countries. The UK works in partnership with India under the … Continue reading Indian Govt invited application for NEWTON-BHABHA fund PhD Programme 2020-2021

National Institute of Animal Biotechnology India could lead to vaccines for bird species against avian paramyxoviruses

Avian paramyxoviruses (APMVs) are a group of 21 virus species isolated from a wide variety of bird species across the globe. The most well characterized of them, APMV-1, popularly known as Newcastle disease virus, causes severe disease in chickens causing huge economic loss to farmers. APMVs are similar to other paramyxoviruses such as Measles and Mumps viruses, enveloped and carry a negative sense, non-segmented RNA … Continue reading National Institute of Animal Biotechnology India could lead to vaccines for bird species against avian paramyxoviruses

National Institute of Immunology found substitution of α-helix with a flexible peptide as linker protein for enhanced GMP formation

National Institute of Immunology (NII), New Delhi’s scientists found that substitution of the helix with a flexible peptide sequence in the full-length hGBP-1 (termed as linker protein) effective in GMP formation. Unlike wild-type, the linker protein is not capable of undergoing substrate-induced oligomerization, suggesting the importance of the helix in oligomerization during the GTP hydrolysis. Furthermore, they examined the effect of interactions between this helix … Continue reading National Institute of Immunology found substitution of α-helix with a flexible peptide as linker protein for enhanced GMP formation